Creegan & Nassoura Financial Group, LLC Sanofi Transaction History

Creegan & Nassoura Financial Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$48.99 - $57.46 $450,708 - $528,632	-9,200 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$48.48 - $53.65 $192,708 - $213,258	-3,975 Reduced 30.17%	9,200 $472,000
Q4 2021 Feb 14, 2022	SELL	$47.07 - $52.35 $27,065 - $30,101	-575 Reduced 4.18%	13,175 $660,000
Q3 2021 Nov 15, 2021	SELL	$47.89 - $53.12 $8,380 - $9,296	-175 Reduced 1.26%	13,750 $663,000
Q2 2021 Aug 16, 2021	SELL	$49.36 - $54.25 $756,442 - $831,381	-15,325 Reduced 52.39%	13,925 $733,000
Q1 2021 May 17, 2021	SELL	$45.46 - $50.51 $88,647 - $98,494	-1,950 Reduced 6.25%	29,250 $1.45 Million
Q4 2020 Feb 16, 2021	SELL	$45.3 - $51.62 $4,530 - $5,162	-100 Reduced 0.32%	31,200 $1.52 Million
Q4 2019 Feb 14, 2020	BUY	$44.25 - $50.86 $1.39 Million - $1.59 Million	31,300 New	31,300 $1.57 Million

810

267M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $136B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Creegan & Nassoura Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Creegan & Nassoura Financial Group, LLC with notifications on news.